Yarbrough Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Yarbrough Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,748	Closed	-$137K	–	256
2022 Q4	$137K	Buy	+3,748	New	+$148K	0.01%	180
2022 Q3	–	Sell	-3,748	Closed	-$269K	–	198
2022 Q2	$269K	Sell	3,748 -781	-17%	-$57.1K	0.02%	163
2022 Q1	$367K	Buy	4,529 +781	+21%	+$66.1K	0.02%	174
2021 Q4	$385K	Buy	+3,748	New	+$360K	0.02%	163

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Yarbrough Capital's SYNH Position: Q1 2023 in Review

Yarbrough Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 3,748 shares — an estimated $137K sold.

Yarbrough Capital first reported a position in SYNH in Q4 2021 and held it in 4 quarters. The position peaked at $385K in Q4 2021. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

Yarbrough Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Yarbrough Capital sold 3,748 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $137K.
Yarbrough Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 4 quarters.
Yarbrough Capital's Syneos Health, Inc. Class A Common Stock position peaked at $385K in Q4 2021.
305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Yarbrough Capital's 13F filing for Q1 2023, filed 13 Apr 2023.